RES vs. BTCY

Last updated Apr 1, 2026

Compare and contrast key facts about RPC, Inc. (RES) and Biotricity, Inc. (BTCY).

Performance

RES vs. BTCY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in RPC, Inc. (RES) and Biotricity, Inc. (BTCY). The values are adjusted to include any dividend payments, if applicable.

RES vs. BTCY - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
RES RPC, Inc.	31.06%	-5.49%	-16.39%	-16.42%	96.73%	44.13%	-39.89%	-46.14%	-60.21%	29.61%
BTCY Biotricity, Inc.	-21.32%	3.50%	-74.80%	-57.22%	-88.74%	439.11%	17.18%	31.25%	-93.68%	194.22%

Fundamentals

Market Cap RES : $1.50B BTCY : $6.51M
EPS RES : $0.15 BTCY : -$0.17
PS Ratio RES : 0.94 BTCY : 0.41
Total Revenue (TTM) RES : $1.63B BTCY : $15.45M
Gross Profit (TTM) RES : $393.68M BTCY : $12.53M
EBITDA (TTM) RES : $216.94M BTCY : $267.47K

Returns By Period

In the year-to-date period, RES achieves a 31.06% return, which is significantly higher than BTCY's -21.32% return. Over the past 10 years, RES has outperformed BTCY with an annualized return of -5.28%, while BTCY has yielded a comparatively lower -33.92% annualized return.

RES

• 1D: -0.98%
• 1M: 21.86%
• YTD: 31.06%
• 6M: 50.89%
• 1Y: 32.85%
• 3Y*: -0.12%
• 5Y*: 6.47%
• 10Y*: -5.28%

BTCY

• 1D: -9.22%
• 1M: -9.65%
• YTD: -21.32%
• 6M: -55.46%
• 1Y: -30.58%
• 3Y*: -56.10%
• 5Y*: -55.68%
• 10Y*: -33.92%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

RES vs. BTCY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RES

RES Risk / Return Rank: 64
RES Sharpe Ratio Rank: 65
RES Sortino Ratio Rank: 60
RES Omega Ratio Rank: 61
RES Calmar Ratio Rank: 69
RES Martin Ratio Rank: 64

BTCY

BTCY Risk / Return Rank: 32
BTCY Sharpe Ratio Rank: 31
BTCY Sortino Ratio Rank: 45
BTCY Omega Ratio Rank: 42
BTCY Calmar Ratio Rank: 22
BTCY Martin Ratio Rank: 21

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

RES vs. BTCY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for RPC, Inc. (RES) and Biotricity, Inc. (BTCY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	RES	BTCY	Difference
Sharpe ratio Return per unit of total volatility	0.66	-0.23	+0.89
Sortino ratio Return per unit of downside risk	1.16	0.59	+0.57
Omega ratio Gain probability vs. loss probability	1.17	1.06	+0.10
Calmar ratio Return relative to maximum drawdown	1.36	-0.61	+1.97
Martin ratio Return relative to average drawdown	2.49	-1.13	+3.63
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

RES vs. BTCY - Sharpe Ratio Comparison

The current RES Sharpe Ratio is 0.66, which is higher than the BTCY Sharpe Ratio of -0.23. The chart below compares the historical Sharpe Ratios of RES and BTCY, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	RES	BTCY	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.66	-0.23	+0.89
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.12	-0.45	+0.57
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	-0.09	-0.26	+0.17
Sharpe Ratio (All Time) Calculated using the full available price history	0.20	-0.26	+0.47

Correlation

The correlation between RES and BTCY is 0.01, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

RES vs. BTCY - Dividend Comparison

RES's dividend yield for the trailing twelve months is around 2.26%, while BTCY has not paid dividends to shareholders.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
RES RPC, Inc.	2.26%	2.94%	2.69%	2.20%	0.45%	0.00%	0.00%	2.86%	4.76%	0.51%	0.25%	1.30%
BTCY Biotricity, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Drawdowns

RES vs. BTCY - Drawdown Comparison

The maximum RES drawdown since its inception was -92.34%, smaller than the maximum BTCY drawdown of -99.67%. Use the drawdown chart below to compare losses from any high point for RES and BTCY.

Drawdown Indicators

	RES	BTCY	Difference
Max Drawdown Largest peak-to-trough decline	-92.34%	-99.67%	+7.33%
Max Drawdown (1Y) Largest decline over 1 year	-24.83%	-71.22%	+46.39%
Max Drawdown (5Y) Largest decline over 5 years	-63.75%	-99.29%	+35.54%
Max Drawdown (10Y) Largest decline over 10 years	-92.34%	-99.67%	+7.33%
Current Drawdown Current decline from peak	-69.80%	-99.61%	+29.81%
Average Drawdown Average peak-to-trough decline	-37.35%	-75.61%	+38.26%
Ulcer Index Depth and duration of drawdowns from previous peaks	13.58%	38.23%	-24.65%

Volatility

RES vs. BTCY - Volatility Comparison

The current volatility for RPC, Inc. (RES) is 9.38%, while Biotricity, Inc. (BTCY) has a volatility of 37.80%. This indicates that RES experiences smaller price fluctuations and is considered to be less risky than BTCY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	RES	BTCY	Difference
Volatility (1M) Calculated over the trailing 1-month period	9.38%	37.80%	-28.42%
Volatility (6M) Calculated over the trailing 6-month period	35.11%	86.01%	-50.90%
Volatility (1Y) Calculated over the trailing 1-year period	49.79%	134.29%	-84.50%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	53.60%	125.14%	-71.54%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	57.18%	130.21%	-73.03%

Financials

RES vs. BTCY - Profitability Comparison

The chart below illustrates the profitability comparison between RPC, Inc. and Biotricity, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

RES - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, RPC, Inc. reported a gross profit of 89.21M and revenue of 425.78M. Therefore, the gross margin over that period was 21.0%.

BTCY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Biotricity, Inc. reported a gross profit of 3.25M and revenue of 3.99M. Therefore, the gross margin over that period was 81.5%.

RES - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, RPC, Inc. reported an operating income of -3.99M and revenue of 425.78M, resulting in an operating margin of -0.9%.

BTCY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Biotricity, Inc. reported an operating income of 440.92K and revenue of 3.99M, resulting in an operating margin of 11.1%.

RES - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, RPC, Inc. reported a net income of -3.06M and revenue of 425.78M, resulting in a net margin of -0.7%.

BTCY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Biotricity, Inc. reported a net income of -1.15M and revenue of 3.99M, resulting in a net margin of -28.8%.